Pulse Biosciences Bought 15,000: What It Means for Investors
A notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Target date funds adjust asset allocations over time toward a chosen retirement year, simplifying diversification and rebalancing for many savers.
19,808 articlesA notable insider purchase by Pulse Biosciences’ CEO draws attention from investors. This article breaks down what th...
Ethereum faces fresh waves of skepticism in May 2026 as prices retreat and social chatter shifts from optimism to dou...
Despite regulatory progress and new market access, XRP has struggled to break out in 2026. This piece analyzes whethe...
Jim Cramer reframes Nokia’s story from a smartphone casualty to an AI infrastructure play, highlighting the stock’s s...
Two Harbors postpones its special meeting to vote on its sale to CrossCountry Mortgage, while pushing UWM to submit a...
XRP trades near $1.15 as sentiment tumbles to multi-month lows. History shows a similar lull preceded a sharp rebound...
High-priced tech names can deliver big gains if growth sticks. This article breaks down how to evaluate the momentum,...
A Dream Finders insider sale grabbed attention after the stock dropped nearly 30%. This guide breaks down what know a...
A Paris court setback keeps the ownership fight over the Miraval winery alive as investors weigh the financial stake ...
Tom Lee of Fundstrat says July could lift U.S. stocks as valuations normalize after June volatility, supported by eas...
Investors await Intuitive Surgical’s Q2 release after a sharp YTD decline. Live updates will track da Vinci growth, u...
A federal court in Tennessee blocked state enforcement actions against Kalshi, citing a likelihood the contracts may ...